NCT02796612

Brief Summary

The project investigates prospectively whether anxiety in the context of breast biopsy can be reduced by the planed intervention (take-home brochure and structured and standardized information given by a psychologically trained physician who performs the biopsy).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for not_applicable anxiety

Timeline
Completed

Started Apr 2014

Longer than P75 for not_applicable anxiety

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2014

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

July 17, 2015

Completed
11 months until next milestone

First Posted

Study publicly available on registry

June 13, 2016

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 5, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 5, 2018

Completed
Last Updated

November 13, 2018

Status Verified

November 1, 2018

Enrollment Period

4.5 years

First QC Date

July 17, 2015

Last Update Submit

November 8, 2018

Conditions

Keywords

anxietybreast cancer, suspectedbreast biopsyempathystandardized and structured informationanxiety reduction

Outcome Measures

Primary Outcomes (1)

  • Reduction of level of anxiety compared between arm 'no intervention' and arm 'intervention' as measured via questionnaires

    up to 19 months

Secondary Outcomes (6)

  • level of anxiety in the intervention group during and after biopsy measured via questionnaires

    up to 19 months

  • correlation of the level of anxiety and the histological diagnosis of breast cancer measured via questionnaires

    up to 19 months

  • perception of pain during and after biopsy measured via pain score

    up to 19 months

  • influence of waiting time between biopsy and histological diagnosis on the level of anxiety measured via questionnaires

    up to 19 months

  • correlation of patient's perception of pain and anxiety and physician's impression of patient's perception measured by questionnaires

    up to 19 months

  • +1 more secondary outcomes

Study Arms (2)

No intervention

ACTIVE COMPARATOR

Patients receive the current standard of care and are asked to answer the questionnaires mentioned below.

Other: no intervention

Intervention group

EXPERIMENTAL

Patients receive the current standard of care and are asked to answer the questionnaires mentioned below. Additionally, delivery of a take-home brochure to the patients during the first visit is planned. The biopsy is explained to the patient and performed by a psychological trained physician. Patient care by a psychologically trained physician is performed in the sense that patients are informed about their biopsy result by a specifically trained physician.

Other: no interventionBehavioral: delivery of a take-home brochureBehavioral: patient care by a psychologically trained physician

Interventions

Patients do not receive any interventions but are treated according to current standard of care.

Intervention groupNo intervention

Content of brochure is dealing with symptoms, as well as mammographic and ultrasound findings, which need further investigation, will be addressed. The procedure of the breast biopsy itself will be explained in detail. The time in which the histological diagnosis can be expected will be indicated and follow up in case of a benign histology and the necessary therapy in case of breast cancer will be addressed.

Intervention group

The physicians who perform the biopsies will be instructed by means of a psychological training how to give structured and standardized information in order not only to inform comprehensively, but also to meet the patients' emotional needs.

Intervention group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • women who speak and understand German
  • women who will need a skin biopsy, core biopsy or a vacuum assisted biopsy.

You may not qualify if:

  • women receiving a fine needle Aspiration
  • women receiving an examination of a pathologic nipple secretion
  • women receiving an abscess evacuation
  • women who do not speak and understand German

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University Hospital of Basel

Basel, Canton of Basel-City, 4031, Switzerland

Location

Claraspital

Basel, Canton of Basel-City, Switzerland

Location

GZO Wetzikon

Wetzikon, Canton of Zurich, Switzerland

Location

Related Publications (1)

  • Machacek M, Urech C, Tschudin S, Werlen L, Schoenenberger CA, Zanetti-Dallenbach R. Impact of a brochure and empathetic physician communication on patients' perception of breast biopsies. Arch Gynecol Obstet. 2023 Nov;308(5):1611-1620. doi: 10.1007/s00404-023-07058-w. Epub 2023 May 20.

MeSH Terms

Conditions

Anxiety DisordersBreast Neoplasms

Condition Hierarchy (Ancestors)

Mental DisordersNeoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Rosanna Zanetti, PD Dr. MD

    Claraspital Basel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 17, 2015

First Posted

June 13, 2016

Study Start

April 1, 2014

Primary Completion

October 5, 2018

Study Completion

October 5, 2018

Last Updated

November 13, 2018

Record last verified: 2018-11

Locations